Article
Effect of angiotensin-converting enzyme inhibition on restenosis after coronary stenting.
The American journal of cardiology - 15 Jan 2003
Ribichini Flavio, Wijns William, Ferrero Valeria, Matullo Giuseppe, Camilla Terenzio, Feola Mauro, Guarrera Simonetta, Vado Antonello, Piazza Alberto, Uslenghi Eugenio
Abstract excerpt
The Plasma level of angiotensin-converting enzyme (ACE) has been identified as a major risk factor for restenosis after coronary stent implantation in selected patients; ACE inhibition may therefore contribute to prevent its occurrence. The effect of oral ACE inhibition at conventional doses was analyzed retrospectively in a series of 897 patients with ischemia who received >or=1 coronary stent on 998 lesions and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
